Alkem Laboratories announced the launch of generic empagliflozin and its combinations in India under the brand name Empanorm at prices that are approximately 80% lower than the innovator products.

Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to ...

The solution is bioequivalent and therapeutically equivalent to the reference listed drug and will be available through the same ophthalmic channels as the company’s existing eye care portfolio.